Brigit Biofarmaka Teknologi Tbk. vs Sunindo Pratama Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Sunindo Pratama Tbk. trades at Rp620 (market cap 1.63T, 2.86M 24h volume). The key difference: Sunindo Pratama Tbk. is far larger — about 9.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sunindo Pratama Tbk. is more actively traded (2.86M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SUNI | |
|---|---|---|
Market Cap | 172.82B | 1.63T |
Volume | 592.2K | 2.86M |
Lot | 5.92K | 28.59K |
Turnover | 147.05M | 1.74B |
Average Price | 248.31 | 610.28 |
Value | 147.05M | 1.74B |
Indicative Equilibrium Price | 254 | 620 |
Indicative Equilibrium Volume | 10 | 344 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sunindo Pratama Tbk (The Company) was established based on Notarial Deed of Shinta Dewi Sudarsana, S.H., No. 04 dated October 17, 2002.
Read more on SUNI →